February 1, 2022 01:39 PM EST
R&D

Bak­er's dozen: Pfiz­er joins 12 peers in re­strict­ing sales of dis­count­ed drugs un­der a fed­er­al pro­gram

Zachary Brennan

Senior Editor

Be­gin­ning in March, Pfiz­er will be­come the 13th phar­ma com­pa­ny to re­strict sales of its drugs through a fed­er­al pro­gram that of­fers steep dis­counts for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

As blue­bird projects more com­mer­cial de­mand, the biotech con­tin­ues to seek cash

Zai Lab aims to raise $200M; Kro­nos Bio to seek ‘strate­gic’ op­tions

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times